A Nobel Prize Winning History

An innovative path to the future

A Nobel Prize Winning History

An innovative path to the future

RNAi technologies that make immune cells more effective in killing tumor cells

RNAitechnologies that make immune cells more effective in killing tumor cells

Who we are

We’re a clinical stage biotech co-founded by the Nobel scientist who discovered RNA interference.

Our Science

Our proprietary INTASYL® technology is a platform for self-delivering RNAi immuno-oncology therapies.

Pipeline

Phio is focused on key initiatives for the treatment of cutaneous Squamous Cell Carcinoma (cSCC) and melanoma.

Investors

Phio has brought on new leadership as it pivots from discovery to development.

Latest News